VAERS reports by lot

GSK Varicella/Shingles lot BF4J5: VAERS reports

62 VAERS reports list lot BF4J5 as a GSK Varicella/Shingles vaccine, received between 2019-03-27 and 2021-03-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
62
Reports
5%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5827%
General / Systemic (non-local)3918%
Dermatological (non-injection-site)2512%
Neurological2210%
Cardiac / Cardiovascular178%
Musculoskeletal178%
Allergic / Anaphylactic168%
Gastrointestinal147%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological10%
Respiratory10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California9
Pennsylvania5
New York5
Florida4
Indiana3
Colorado3
Iowa3
Michigan2
Virginia2
Kentucky2
Delaware2
Missouri2

Reports by month received

2019-031
2019-0427
2019-0513
2019-062
2019-074
2019-083
2019-093
2019-121
2020-012
2020-022
2020-031
2020-061
2020-081
2021-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.